Development and characterization of a multimeric recombinant protein using the spike protein receptor binding domain as an antigen to induce SARS-CoV-2 neutralization.

Veronica A de LimaJoão P S NunesDaniela S RosaRodrigo FerreiraMaria L V OlivaRobert Andreata-SantosMarcia Duarte-BarbosaLuiz M R JaniniJuliana T MaricatoMilena A AkamatsuPaulo L HoSergio Schenkman

Published in: Immunity, inflammation and disease (2024)

These results add a new arsenal to combat COVID-19, as an alternative immunogen or antigen for diagnosis.

Keyphrases

sars cov
binding protein
coronavirus disease
protein protein
respiratory syndrome coronavirus
amino acid
small molecule